Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Global CRISPR Market (Genome Editing) is expected to reach $268 million by 2021 Geographical Analysis Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
Molecular Diagnostics Industry Analysis Report, 2016 To 2024Signitech
Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market is expected to witness significant growth over the forecast period owing to rapid surge of infectious diseases.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 - 2025
Liquid Biopsy Global Market estimated to be worth $8,730.4 million by 2024Vinay Shiva Prasad
Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for invasive procedures. Raising incidence of cancer and late pregnancies are driving this market.
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments.
Viral Vector and Plasmid DNA Manufacturing Market Insights, 2019 to 2025Signitech
The global viral vector and plasmid DNA manufacturing market size was valued at USD 270.2 million in 2017.It is anticipated to witness a CAGR of about 16.0% during the forecast period.
“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”Vinay Shiva Prasad
Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced . In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Global CRISPR Market (Genome Editing) is expected to reach $268 million by 2021 Geographical Analysis Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
Molecular Diagnostics Industry Analysis Report, 2016 To 2024Signitech
Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market is expected to witness significant growth over the forecast period owing to rapid surge of infectious diseases.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 - 2025
Liquid Biopsy Global Market estimated to be worth $8,730.4 million by 2024Vinay Shiva Prasad
Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for invasive procedures. Raising incidence of cancer and late pregnancies are driving this market.
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments.
Viral Vector and Plasmid DNA Manufacturing Market Insights, 2019 to 2025Signitech
The global viral vector and plasmid DNA manufacturing market size was valued at USD 270.2 million in 2017.It is anticipated to witness a CAGR of about 16.0% during the forecast period.
“Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”Vinay Shiva Prasad
Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced . In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years.
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
Global Biotechnology Market is estimated to reach $726.8 billion by 2025; growing at a CAGR of 8.1% from 2017 to 2025. Biotechnology is the technology to upgrade or modify the whole part of biological system for human and industrial welfare. It is defined as the industrial application of living organisms and their biological processes such as microbiology, genetic engineering, biochemistry among others, so as to make best usage of the microorganisms for the benefit of mankind. Industrial biotechnology application has also steered some clear processes that produces less waste, less energy and water. It is also used in various industrial sectors such as pulp chemical, paper, textiles, minerals and metal industries, among others.
Global in vitro diagnostics (ivd) market (technique, product, usability, appl...Allied Market Research
"In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020).
The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032.
More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market
The global organ-on-a-chip market generated revenue of US$ 23.3 million in 2020 and is expected to reach US$ 116.7 million by 2025 with a CAGR of 38.0% in the forecast period. The organ-on-a-chip market report offers a comprehensive market analysis of the different segments and regions that lets readers make crucial business-related decisions with a wealth of information enclosed in this report. The research report offers both qualitative and quantitative information on the global organ-on-a-chip market. In qualitative terms, the organ-on-a-chip market report provides insights into numerous factors, such as market determinants, value chain analysis, emerging trends, growth opportunity analysis, porters five-force model analysis and macro-economic factors, segment analysis, regional analysis at a granular level. Similarly, in quantitative terms, the report provides historical and forecast market numbers of organ-on-a-chip in various segments such as by Offerings, type, application & end-user at global, regional, and country-level. Also, the report provides a detailed analysis of the market vendors and their product offerings. The report also covers details of the competitive market environment and includes information on the capabilities and competencies of market vendors.
Europe DNA Sequencing Products Market by Product Type, Distribution Channel, ...IMARC Group
The Europe DNA sequencing products market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028.
More Info:- https://www.imarcgroup.com/europe-dna-sequencing-products-market
5 Cutting-Edge Trends in Molecular DiagnosticsBruce Carlson
Despite the focus on novelty in this field, it is near 2 decades old. Yet a lot is changing. A look at a few trends that could change molecular diagnostics.
Organ-on-chip Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/organ-on-chip-market
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...IMARC Group
The global veterinary diagnostics market size reached US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/veterinary-diagnostics-market
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...MarketResearch.com
A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.
The global in-vitro diagnostics market size was valued at US$ 60,274.1 million in 2017, and is expected to exhibit a CAGR of 4.6% over the forecast period (2018–2026).
DNA Sequencing Products Market by Product Type, Distribution Channel, End Use...IMARC Group
The global DNA sequencing products market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.76% during 2023-2028.
More Info:- https://www.imarcgroup.com/dna-sequencing-products-market
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Global Next Generation Sequencing (NGS) Industry By Market Size & Forecast to...DavidClark206
This research report covers end-to-end market for NGS in terms of the workflow; presequencing, NGS platforms, consumables and services, sequencing services and bioinformatics market. From an insight perspective, this research report focuses on the qualitative data, market size, share, and growth of various segments and sub-segments, competitive landscape, and company profiles.
Inquire For Discount (Single User Report Price US $4650) @ http://www.reportsnreports.com/contacts/Discount.aspx?name=257153 .
The Indian in vitro diagnostic market - an overviewSchenella Menda
Looking for data on the Indian IVD market? Here is an overview of the market, its segments and a brief description of every segment. I hope you enjoy reading it.
Singapore Medical Tourism Analysis and ForecastRenub Research
Renub Research (http://www.renub.com/report/singapore-medical-tourism-analysis-and-forecast-132) has announced the addition of the "Singapore Medical Tourism Analysis and Forecast" report to its offering
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015Renub Research
If online travel and classifieds were the star performers of the last decade, e-retailing seems to be hogging the limelight this time around. India is rapidly emerging as a rewarding market for many e-retailing companies; who are currently present in the market with any one of the three forms (Non-warehouse, Warehouse and Hybrid) models. The broadband and mobile penetration, 3G rollout, cash on delivery, internet banking has led to rise in online transactions by 18.2% for the year 2011 compared to 2010. Indian e-retail market is also expected to be more than INR 10,000 Crore by 2015.
In our analysis we found that Computer peripherals, Camera & Mobile and Life Style segments are expected hold 1st, 2nd and 3rd positions respectively for 2011. Together they account for more than 70% of total market share in 2011. But by the end of 2015 Camera and Mobile is expected to take the top slot pushing computer peripheral to third position. In companies analysis segment Flipkart is the undisputed leader for the year 2011. Flipkart generated 4 times more revenue than its nearest competitor Yebhi in 2011. However according to our research findings scenario is likely to change in 2012 as Myntra is expected to take the second position leaving Yebhi to third position. For the year 2014 Flipkart and Myntra together is expected to hold more than 50% market share.
In any retail business, some products are returned from the point of consumption. Therefore, the challenge is to set up infrastructure and procedures for reverse logistics. The e-tailors need to have an understandable product return policy on the Web. This report provides a clear picture about the e-retailing scenario in India and its various issues like: Types of business model in Indian e-retail, key companies funding and revenue forecast, driving forces for e-retail, challenges in the e-retail.
Renub Research report entitled “India E-Retail (E-Tailing) Market, Companies Revenue Analysis & Forecast to 2015” provides a comprehensive assessment of the fast-evolving, high-growth e-retail space. We recommend this report as must-read insight for e-retailing stakeholders.
The report covers the following points
• E-Retail business model in India
• India e-retail users transacting online growth forecast from (2010 to 2015)
• Studied growth forecasts and India e-retail market sizing from (2009 to 2015)
• Key players revenue analysis, forecast and funding trends of: Flipkart, Letsbuy, Myntra, HomeShop18, Yebhi, Snapdeal and Naptol from (2010 – 2014)
• Market analysis and forecast for segments: Camera & Mobile, Computer Peripherals, Electronic gadgets, Life style, Books amd Home & kitchen Appliances (2009 – 2015)
• Researched the drivers and challenges for the e-retail industry in India.
Contact Us
Andy Hill
Relationship Manager
Sales & Marketing Div
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) +91-120-254-5750 (India)
Web: http://www.renub.com/
http://renub.com/report/india-frozen-food-poultry-fishseafood-red-meat-dessert-snacks-and-vegetable-market-volume-forecast-to-2017-92
Renub Research has announced the addition of the "India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) Market, Volume & Forecast to 2017" report to its offering
Renub Research study titled “India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) Market, Volume & Forecast to 2017” provides a comprehensive assessment of the fast-evolving, high-growth India frozen food Market. This 99 page report with 44 Figures and 26 Tables provides information on frozen food market and market share by value & volume, frozen food products segmentation by value and volume, frozen food products segmentations by packet value and volume; with key companies’ strategies in India frozen food market. This report also identifies the key growth drivers and challenges of the industry. Primary research on consumer preferences of various packet sizes of frozen food products captured in this report.
India Frozen Food covered in this report has been studied from following view points:
• Primary Research - Consumer Survey on Preferences of Packet Sizes of Frozen Foods in Indian Market
• India Frozen Food Market Value (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Value Share (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Volume (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Volume Share (2010 – 2012) and Forecast (2013 – 2017)
• By Value - India Frozen Food Product Market Segmentation (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Analysis by Packet Size (0-300 Gram, 301-500 Gram, 500 Gram-1 Kg, More than 1 Kg) for Year (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Segmentation Analysis by Packet Size (0-300 Gram, 301-500 Gram, 500 Gram-1 Kg, More than 1 Kg) for Year (2010 – 2012) and Forecast (2013 – 2017)
• By Packet Size Market Value - India Frozen Food Product Segmentation (Meat, Dessert, Fish/Seafood, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
• By Volume - India Frozen Food Product Market Segmentation (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
• By Packet Size Volume - India Frozen Food Product Market Segmentation (Meat, Fish/Seafood, Dessert, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
Contact Us
Andy Hill
Sr. Manager - Publisher Relation
Relationship Manager
Sales & Marketing Div
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) +91-120-254-5750, +91-120-4219-822(India)
Web: http://www.renub.com
4 g (lte and wimax) service revenuemarket analysis and its opportunities for ...Renub Research
Renub Research (http://www.renub.com/report/4g-lte-and-wimax-service-revenuemarket-analysis-and-its-opportunities-for-industries-51) has announced the addition of "4G (LTE and WiMAX) Service Revenue/Market Analysis and its Opportunities for Industries" report to its offering
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015Renub Research
Renub Research (http://www.renub.com/report/india-e-retail-e-tailing-market-companies-revenue-analysis-forecast-to-2015-65) has announced the addition of the "India E-Retail (E-Tailing) Market, Companies Revenue Analysis & Forecast to 2015" report to its offering
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Cardivascular bioimplant market analysis publisherRenub Research
Renub Research (http://www.renub.com/report/global-cardiac-bio-implant-devices-implantable-cardioverter-defibrillators-implantable-cardiac-pacemakers-heart-valve-coronary-stent-peripheral-stent-ventricular-assist-device-market-forecast-clinical-trials-ma-115) has announced the addition of the "Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A" report to its offering
South korea medical tourism number of medical tourists & medical tourism mark...Renub Research
Renub Research (http://www.renub.com/report/south-korea-medical-tourism-number-of-medical-tourists-medical-tourism-market-forecast-to-2015-70) has announced the addition of the "South Korea Medical Tourism: Number of Medical Tourists & Medical Tourism Market Forecast to 2015" report to its offering
Pediatric vaccines market, doses, immunization, cases and forecast worldwide ...Renub Research
Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to its offering
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.
Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.
India probiotic dairy products (yogurt, drink, ice cream) market, volume & fo...Renub Research
India probiotic market, probiotic drink market, probiotic ice cream market, probiotic yogurt market, probiotic drink sales, probiotic ice cream sales, probiotic yogurt sales, Nestle probiotic revenue,Amul probiotic revenue, Mother Dairy probiotic revenue, yakult probiotic revenue
Indian Probiotic Dairy industry is evolving at a steady pace with opportunities for tremendous growth in near future. India being the largest producer of milk and having world’s highest cattle population has a distinct advantage in the Probiotic field. Indian Probiotic industry is expected to be more than double by 2015 from its current size in 2011. Brands that exist now in Indian Probiotic industry are Nestle, Amul, Yakult Danone and Mother Dairy along with other minor players operating in different regions in their own capacities. Although there are quite a number of challenges in front of domestic and foreign companies entering the Indian Probiotic market, but the advantages associated with the industrial growth prospects outnumber the challenges in an easy and elegant way. The strong fundamental factors for the Probiotic industry in India will pave way for the growth of Indian Dairy Industry in the near future.
Indian Probiotic Dairy Market, Market Share and Forecast:
Amul is the leader with nearly 70% market share in 2011 and is likely to be at the top in the coming years as well. In 2011, Amul Probiotic share accounted for more than double than the combined share of its competitors like Mother Dairy, Nestle and Yakult. Nestle and Mother Dairy is holding second and third position in the Indian Probiotic Market.
Probiotic Dairy Products (Yougurt, Ice Cream, Drink) and Forecast:
Probiotic Yogurt is the leading category which accounts for more than 50% share in 2011 followed by Probiotic Ice Cream and Probiotic drink.
Probiotic Dairy Products Sales Volume and Forecast:
It is expected that Probiotic yogurt sales will cross 100,000 Thousand packets by 2015. Amul is the leader in Probiotic yogurt sales in India and is likely to remain as a leader in the years to come. Probiotic drink sales volume is likely to reach a little less than 100,000 Thousand bottles by the year 2015. In probiotic drink sales volume, Yakult is way ahead than Mother Dairy. Being a lonely player in the probiotic ice cream market in India Amul is gaining advantage.
Although there are formidable challenges to be encountered, the prospects of the market expanding in a steadfast way look bright. As Probiotics are not previewed under any health related law in India and with Indian Council of Medical Research (ICMR) still framing the guidelines for Probiotic sales (ICMR status report on Probiotics, 2009), Probiotics face no hindrance from government health officials on its sales.
Renub Research (http://www.renub.com/report/india-cold-chain-storage-number-market-capacity-forecast-to-2017-91) has announced the addition of the "India Cold Chain Storage Number, Market & Capacity Forecast to 2017" report to its offering
The cold chain industry also considered the sunrise Industry in India because of its robust future outlook. As with high growth prospects for the food processing sector along with attractive government incentives including 51 percent FDI clearance in multi brand retail makes cold chain business a goldmine for foreign investors as well.
India Cold Storage Market Analysis:
• In the year 2012, India cold storage market was XXXX with a combined capacity of XXXX Thousand Metric Tons
• The surface cold storage accounts for XXXX% of the total cold storage market compared to XXXX% of refrigerated transportation in 2012
• In India cold storage market for potato holds the maximum share of XXXX% in 2012.
• The market share of multipurpose cold storage will be XXXX% share by 2017. It is projected that meat and fish will be at 3rd position in the India cold storage market with XXXX% share by 2017
• The fruits & vegetables cold storage market in India was worth US$ XXXX Million in 2012 and it is forecasted to reach US$ XXXX Million by 2017
• The milk and products cold market is expected to account for XXXX% in 2017
India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vege...Renub Research
Renub Research (http://renub.com/report/india-frozen-food-poultry-fishseafood-red-meat-dessert-snacks-and-vegetable-market-volume-forecast-to-2017-92) has announced the addition of the "India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) Market, Volume & Forecast to 2017" report to its offering
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Company Valuation webinar series - Tuesday, 4 June 2024FelixPerez547899
This session provided an update as to the latest valuation data in the UK and then delved into a discussion on the upcoming election and the impacts on valuation. We finished, as always with a Q&A
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.AnnySerafinaLove
This letter, written by Kellen Harkins, Course Director at Full Sail University, commends Anny Love's exemplary performance in the Video Sharing Platforms class. It highlights her dedication, willingness to challenge herself, and exceptional skills in production, editing, and marketing across various video platforms like YouTube, TikTok, and Instagram.
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
Digital Transformation and IT Strategy Toolkit and TemplatesAurelien Domont, MBA
This Digital Transformation and IT Strategy Toolkit was created by ex-McKinsey, Deloitte and BCG Management Consultants, after more than 5,000 hours of work. It is considered the world's best & most comprehensive Digital Transformation and IT Strategy Toolkit. It includes all the Frameworks, Best Practices & Templates required to successfully undertake the Digital Transformation of your organization and define a robust IT Strategy.
Editable Toolkit to help you reuse our content: 700 Powerpoint slides | 35 Excel sheets | 84 minutes of Video training
This PowerPoint presentation is only a small preview of our Toolkits. For more details, visit www.domontconsulting.com
In the Adani-Hindenburg case, what is SEBI investigating.pptxAdani case
Adani SEBI investigation revealed that the latter had sought information from five foreign jurisdictions concerning the holdings of the firm’s foreign portfolio investors (FPIs) in relation to the alleged violations of the MPS Regulations. Nevertheless, the economic interest of the twelve FPIs based in tax haven jurisdictions still needs to be determined. The Adani Group firms classed these FPIs as public shareholders. According to Hindenburg, FPIs were used to get around regulatory standards.
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
2. Global Molecular Diagnostics Market & Future Forecast to 2017 Overview
The global molecular diagnostics market is witnessing a period of profound growth. The growth
is coming from different regions and markets. The next five years will witness significant
developments in molecular diagnostics such as automation, as well as introduction of a wide
range of new products. Molecular Diagnostics involves multiple technologies to identify genetic
variations in individual patients. These technologies include PCR, FISH, hybrid capture,
sequencing and microarrays. The increase in the aging population and incidences of various
chronic diseases are driving the demand of molecular diagnostics world over. The industry is
getting a push from every side and many factors collectively are fuelling the growth in this
industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is
expected to double its market size in 2017 from the market of 2012.
Molecular Diagnostics Market - Application Segment Analysis
The infectious disease testing is the leading application in Molecular Diagnostic. It is
likely to hold XXXX% share in 2017.
Molecular oncology tests have emerged as a second significant rapidly growing market
segment. Genetic Testing and Blood Screening are at the third and fourth spot
respectively in 2012.
The cardiovascular disease testing and neurological testing are closely competing with
each other to gain the maximum market share.
Food testing market is expected to inch up to US$ XXXX Million in 2017.
Molecular Diagnostics Market - Technologies Segment Analysis
Biochips and PCR based test accounts for the largest shares in the molecular diagnostics
technologies segment with XXXX% and XXXX% respectively in 2012.
Fish & Innovations technology market is at the 3rd
slot.